Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $177B | -$1.21B | 202 | 2.65% | Reduced |
|
| 2 |
BlackRock
New York
| $158B | -$802M | 216 | 2.76% | Reduced |
|
| 3 |
State Street
Boston,
Massachusetts
| $88.6B | -$354M | 185 | 3.07% | Reduced |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $42.3B | -$273M | 228 | 2.69% | Reduced |
|
| 5 |
JP Morgan Chase
New York
| $41.3B | +$196M | 177 | 2.48% | Increased |
|
| 6 |
Morgan Stanley
New York
| $38.8B | +$618M | 238 | 2.35% | Increased |
|
| 7 |
Fidelity Investments
Boston,
Massachusetts
| $34.5B | -$1.72B | 155 | 1.79% | Reduced |
|
| 8 |
Charles Schwab
San Francisco,
California
| $25.1B | +$71.5M | 114 | 4.01% | Increased |
|
| 9 |
Wellington Management Group
Boston,
Massachusetts
| $25B | -$1.27B | 70 | 4.38% | Reduced |
|
| 10 |
Bank of America
Charlotte,
North Carolina
| $24.7B | -$121M | 247 | 1.68% | Reduced |
|
| 11 |
Northern Trust
Chicago,
Illinois
| $21.8B | -$128M | 182 | 2.79% | Reduced |
|
| 12 |
T. Rowe Price Associates
Baltimore,
Maryland
| $18.6B | +$654M | 104 | 1.99% | Increased |
|
| 13 |
Capital World Investors
Los Angeles,
California
| $15.2B | +$371M | 14 | 2.07% | Increased |
|
| 14 |
Bank of New York Mellon
New York
| $15B | -$160M | 115 | 2.7% | Reduced |
|
| 15 |
Capital International Investors
Los Angeles,
California
| $15B | -$3.35B | 12 | 2.42% | Reduced |
|
| 16 |
Franklin Resources
San Mateo,
California
| $14.9B | -$1.1B | 73 | 3.72% | Reduced |
|
| 17 |
Goldman Sachs
New York
| $14.4B | +$244M | 147 | 1.77% | Increased |
|
| 18 |
Dimensional Fund Advisors
Austin,
Texas
| $13.8B | +$69.9M | 104 | 2.96% | Increased |
|
| 19 |
UBS AM
Chicago,
Illinois
| $13.4B | -$2.88B | 55 | 2.9% | Reduced |
|
| 20 |
Invesco
Atlanta,
Georgia
| $13.2B | +$549M | 105 | 2.08% | Increased |
|
| 21 |
Legal & General Group
London,
United Kingdom
| $13.2B | +$528M | 104 | 2.96% | Increased |
|
| 22 |
Dodge & Cox
San Francisco,
California
| $12.6B | +$506M | 13 | 6.78% | Increased |
|
| 23 |
Capital Research Global Investors
Los Angeles,
California
| $11.9B | -$248M | 11 | 2.23% | Reduced |
|
| 24 |
Primecap Management
Pasadena,
California
| $11.6B | -$637M | 18 | 8.85% | Reduced |
|
| 25 |
UBS Group
Zurich,
Switzerland
| $11.4B | -$617M | 256 | 1.79% | Reduced |
|